Global Nicotinamide Adenine Dinucleotide (NAD) Market By Type (Pharmaceutical Grade, Food Grade, and Others), By Application Outlook (Dietary Supplement, Pharmaceutical Industry, and Others), By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
Nicotinic acid is also known as nicotin, Vitamin B3, and nicotinamide. Hormone synthesis and growth are both dependent on it. It is a nutrient that aids bodily function by converting food into glucose, which is used to produce energy. NAD is utilised to catalyse chemical reactions that are required to produce energy as well as to construct and repair the molecules that make up our bodies, all of which have an impact on nicotinamide adenine dinucleotide (NAD) market demand and growth. NAD also has a lot of benefits, including the fact that it aids in cell health maintenance. Nicotinamide adenine dinucleotide (NAD) boosters also target cells to slow down the ageing process. It also helps to improve the immune system and repair DNA. Furthermore, it contributes in the growth of strength and the speeding up of metabolism. Because of the benefits listed above, there is an upsurge in demand nicotinamide adenine dinucleotide (NAD) market. Additionally, ageing population and a poor diet is further growing demand. NAD assists you in sleeping and eating at appropriate periods. In addition, as people's discretionary wealth has grown over the world, their lifestyles have evolved. As a result, junk food consumption has skyrocketed. The body's cholesterol levels have become imbalanced as a result of increased junk food consumption. This is expected to boost pharmaceutical demand, resulting in augmented growth for nicotinamide adenine dinucleotide (NAD) market. Tryptophan or nicotinic acid can also be used to make NAD
The "salvage pathway" of NAD production, which requires nicotinamide as a substrate is extremely active in mammalian cells, appears to be exploited extensively by a subset of human malignancies. As a result, NAD may one day be employed to treat a wide range of malignancies. Demand for nicotinamide adenine dinucleotide (NAD) market will rise as the number of cardiovascular illnesses rises around the world. In certain studies, however, excessive NAD use has been related to side effects like nausea, rashes, headaches, dizziness, bloating, and skin disorders like itching and sweating. The marketplace's expansion may be limited as a result of these negative effects.
COVID-19's detrimental effects on the global economic system are also captured in this report. As a result of the epidemic, some businesses incurred severe financial losses. Several firms are striving to rescue the COVID-19 from its predicament. The analysis of nicotinamide adenine dinucleotide (NAD) market covers the key patterns that affected each industry throughout the pandemic. In recent years, the nicotinamide adenine dinucleotide (NAD) market grew at a moderate rate with significant growth rates, and it is likely to increase significantly in the forecast period, i.e. 2022 to 2030.
Global nicotinamide adenine dinucleotide (NAD) market is projected to grow at an estimated CAGR of 15.76% over the forecast period (2022 – 2030).
Global Nicotinamide Adenine Dinucleotide (NAD) Market Revenue & Forecast, (US$ Million), 2015 – 2030
Type Outlook
Pharmaceutical grade category in the global nicotinamide adenine dinucleotide (NAD) market is predicted to grow at the fastest rate over the forecast period. Pharmaceutical-grade supplements are ones that are manufactured to ensure maximum purity and absorption. Pharmaceutical-grade products must also be 99 percent pure, with no fillers, binders, colours, or other inert components acting as a vehicle for active compounds.
Application Outlook
Dietary supplements accounted for the largest market share in the nicotinamide adenine dinucleotide (NAD) market. Nicotinamide adenine dinucleotide (NAD+) is a different type of B3 vitamin that can be found in food or taken as a supplement. It is required for over 500 enzymatic reactions and is involved in the regulation of practically all biological functions. Above all, it holds the promise of assisting us in living better and longer lives. It is also used to treat pellagra and helps to raise HDL levels. Demand for vitamin dietary supplements is increasing as customers have become more mindful of their health.
Region Outlook
America holds the largest share of the nicotinamide adenine dinucleotide (NAD) market, and this trend is projected to continue in the coming years. Consumer awareness of the health benefits is a critical factor in the region's market expansion. Furthermore, as the number of cardiovascular illnesses is seeing an upward trend in this region, the demand for nicotinamide adenine dinucleotide (NAD), is propelling.
Competitive Landscape
The report provides both, qualitative and quantitative research of nicotinamide adenine dinucleotide (NAD) market as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contacts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
List of Key Players in the Global Nicotinamide Adenine Dinucleotide (NAD) Market are:
•Bontac Bio-engineering(shenzhen)co.,ltd
•Catalent, Inc
•Jubilant Life Sciences
•Koninklijke DSM N.V.
•Lasons India Pvt. Ltd
•Lonza Group Ltd
•Novo Nordisk A/S
•Resonance Specialties Limited
•TCI Chemicals (India) Pvt. Ltd.
•Vertellus Holdings LLC
•Zhejiang Lanbo Biotechnology Co., Ltd.
•Other Market Participants
Global Nicotinamide Adenine Dinucleotide (NAD) Market
By Type
- Pharmaceutical Grade
- Food Grade
- Others
By Application
- Dietary Supplement
- Pharmaceutical Industry
- Others
By Region
- North America
- U.S
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1.
Market
Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2015 - 2020
1.2.2. Base Year: 2021
1.2.3. Forecast Years: 2022 – 2030
2.
Key
Target Audiences
3.
Research
Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders
(KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4.
Recommendations
and Insights from AMI’s Perspective**
5.
Holistic
Overview of Nicotinamide Adenine Dinucleotide (NAD) Market
6.
Market
Synopsis: Nicotinamide Adenine
Dinucleotide (NAD) Market
7.
Nicotinamide
Adenine Dinucleotide (NAD) Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in Nicotinamide Adenine Dinucleotide
(NAD) Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators:
Nicotinamide Adenine Dinucleotide (NAD) Market
7.6. Porter’s Five Force Analysis
7.7. Impact of Covid-19 on Nicotinamide Adenine
Dinucleotide (NAD) Market
8.
Global
Nicotinamide Adenine Dinucleotide (NAD) Market Analysis and Forecasts, 2021 –
2029
8.1. Overview
8.1.1. Global Nicotinamide Adenine Dinucleotide
(NAD) Market Revenue (US$ Mn)
8.2. Global Nicotinamide Adenine Dinucleotide
(NAD) Market Revenue (US$ Mn) and Forecasts, By Type
8.2.1. Pharmaceutical Grade
8.2.1.1.
Definition
8.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.1.3.
Market
Forecast, 2022 - 2030
8.2.1.4.
Compound
Annual Growth Rate (CAGR)
8.2.1.5.
Regional
Bifurcation
8.2.1.5.1.
North
America
8.2.1.5.1.1.
Market
Estimation, 2015 - 2021
8.2.1.5.1.2.
Market
Forecast, 2022 - 2030
8.2.1.5.2.
Europe
8.2.1.5.2.1.
Market
Estimation, 2015 - 2021
8.2.1.5.2.2.
Market
Forecast, 2022 - 2030
8.2.1.5.3.
Asia
Pacific
8.2.1.5.3.1.
Market
Estimation, 2015 - 2021
8.2.1.5.3.2.
Market
Forecast, 2022 - 2030
8.2.1.5.4.
Middle
East and Africa
8.2.1.5.4.1.
Market
Estimation, 2015 - 2021
8.2.1.5.4.2.
Market
Forecast, 2022 - 2030
8.2.1.5.5.
Latin
America
8.2.1.5.5.1.
Market
Estimation, 2015 - 2021
8.2.1.5.5.2.
Market
Forecast, 2022 - 2030
8.2.2. Food Grade
8.2.2.1.
Definition
8.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.2.3.
Market
Forecast, 2022 - 2030
8.2.2.4.
Compound
Annual Growth Rate (CAGR)
8.2.2.5.
Regional
Bifurcation
8.2.2.5.1.
North
America
8.2.2.5.1.1.
Market
Estimation, 2015 - 2021
8.2.2.5.1.2.
Market
Forecast, 2022 - 2030
8.2.2.5.2.
Europe
8.2.2.5.2.1.
Market
Estimation, 2015 - 2021
8.2.2.5.2.2.
Market
Forecast, 2022 - 2030
8.2.2.5.3.
Asia
Pacific
8.2.2.5.3.1.
Market
Estimation, 2015 - 2021
8.2.2.5.3.2.
Market
Forecast, 2022 - 2030
8.2.2.5.4.
Middle
East and Africa
8.2.2.5.4.1.
Market
Estimation, 2015 - 2021
8.2.2.5.4.2.
Market
Forecast, 2022 - 2030
8.2.2.5.5.
Latin
America
8.2.2.5.5.1.
Market
Estimation, 2015 - 2021
8.2.2.5.5.2.
Market Forecast,
2022 - 2030
8.2.3. Others
8.2.3.1.
Definition
8.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.3.3.
Market
Forecast, 2022 - 2030
8.2.3.4.
Compound
Annual Growth Rate (CAGR)
8.2.3.5.
Regional
Bifurcation
8.2.3.5.1.
North
America
8.2.3.5.1.1.
Market
Estimation, 2015 - 2021
8.2.3.5.1.2.
Market
Forecast, 2022 - 2030
8.2.3.5.2.
Europe
8.2.3.5.2.1.
Market
Estimation, 2015 - 2021
8.2.3.5.2.2.
Market
Forecast, 2022 - 2030
8.2.3.5.3.
Asia
Pacific
8.2.3.5.3.1.
Market
Estimation, 2015 - 2021
8.2.3.5.3.2.
Market
Forecast, 2022 - 2030
8.2.3.5.4.
Middle
East and Africa
8.2.3.5.4.1.
Market
Estimation, 2015 - 2021
8.2.3.5.4.2.
Market
Forecast, 2022 - 2030
8.2.3.5.5.
Latin
America
8.2.3.5.5.1.
Market
Estimation, 2015 - 2021
8.2.3.5.5.2.
Market
Forecast, 2022 - 2030
8.3. Key Segment for Channeling Investments
8.3.1. By Type
9.
Global
Nicotinamide Adenine Dinucleotide (NAD) Market Analysis and Forecasts, 2021 –
2029
9.1. Overview
9.2. Global Nicotinamide Adenine Dinucleotide
(NAD) Market Revenue (US$ Mn) and Forecasts, By Application
9.2.1. Dietary Supplement
9.2.1.1.
Definition
9.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.1.3.
Market
Forecast, 2022 - 2030
9.2.1.4.
Compound
Annual Growth Rate (CAGR)
9.2.1.5.
Regional
Bifurcation
9.2.1.5.1.
North
America
9.2.1.5.1.1.
Market
Estimation, 2015 - 2021
9.2.1.5.1.2.
Market
Forecast, 2022 - 2030
9.2.1.5.2.
Europe
9.2.1.5.2.1.
Market
Estimation, 2015 - 2021
9.2.1.5.2.2.
Market
Forecast, 2022 - 2030
9.2.1.5.3.
Asia
Pacific
9.2.1.5.3.1.
Market
Estimation, 2015 - 2021
9.2.1.5.3.2.
Market
Forecast, 2022 - 2030
9.2.1.5.4.
Middle
East and Africa
9.2.1.5.4.1.
Market
Estimation, 2015 - 2021
9.2.1.5.4.2.
Market
Forecast, 2022 - 2030
9.2.1.5.5.
Latin America
9.2.1.5.5.1.
Market
Estimation, 2015 - 2021
9.2.1.5.5.2.
Market
Forecast, 2022 - 2030
9.2.2. Pharmaceutical Industry
9.2.2.1.
Definition
9.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.2.3.
Market
Forecast, 2022 - 2030
9.2.2.4.
Compound
Annual Growth Rate (CAGR)
9.2.2.5.
Regional
Bifurcation
9.2.2.5.1.
North
America
9.2.2.5.1.1.
Market
Estimation, 2015 - 2021
9.2.2.5.1.2.
Market
Forecast, 2022 - 2030
9.2.2.5.2.
Europe
9.2.2.5.2.1.
Market
Estimation, 2015 - 2021
9.2.2.5.2.2.
Market
Forecast, 2022 - 2030
9.2.2.5.3.
Asia
Pacific
9.2.2.5.3.1.
Market
Estimation, 2015 - 2021
9.2.2.5.3.2.
Market
Forecast, 2022 - 2030
9.2.2.5.4.
Middle
East and Africa
9.2.2.5.4.1.
Market
Estimation, 2015 - 2021
9.2.2.5.4.2.
Market
Forecast, 2022 - 2030
9.2.2.5.5.
Latin
America
9.2.2.5.5.1.
Market
Estimation, 2015 - 2021
9.2.2.5.5.2.
Market
Forecast, 2022 - 2030
9.2.3. Others
9.2.3.1.
Definition
9.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.3.3.
Market
Forecast, 2022 - 2030
9.2.3.4.
Compound
Annual Growth Rate (CAGR)
9.2.3.5.
Regional
Bifurcation
9.2.3.5.1.
North
America
9.2.3.5.1.1.
Market
Estimation, 2015 - 2021
9.2.3.5.1.2.
Market
Forecast, 2022 - 2030
9.2.3.5.2.
Europe
9.2.3.5.2.1.
Market
Estimation, 2015 - 2021
9.2.3.5.2.2.
Market
Forecast, 2022 - 2030
9.2.3.5.3.
Asia
Pacific
9.2.3.5.3.1.
Market
Estimation, 2015 - 2021
9.2.3.5.3.2.
Market
Forecast, 2022 - 2030
9.2.3.5.4.
Middle
East and Africa
9.2.3.5.4.1.
Market
Estimation, 2015 - 2021
9.2.3.5.4.2.
Market
Forecast, 2022 - 2030
9.2.3.5.5.
Latin
America
9.2.3.5.5.1.
Market
Estimation, 2015 - 2021
9.2.3.5.5.2.
Market
Forecast, 2022 - 2030
9.3. Key Segment for Channeling Investments
9.3.1. By Application
10. North America Nicotinamide Adenine
Dinucleotide (NAD) Market Analysis and Forecasts, 2022 - 2030
10.1. Overview
10.1.1. North America Nicotinamide Adenine
Dinucleotide (NAD) Market Revenue (US$ Mn)
10.2. North America Nicotinamide Adenine
Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts, By Type
10.2.1. Pharmaceutical Grade
10.2.2. Food Grade
10.2.3. Others
10.3. North America Nicotinamide Adenine
Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts, By Application
10.3.1. Dietary Supplement
10.3.2. Pharmaceutical Industry
10.3.3. Others
10.4. North America Nicotinamide Adenine
Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts, By Country
10.4.1. U.S
10.4.1.1.
U.S
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Type
10.4.1.1.1.
Pharmaceutical
Grade
10.4.1.1.2.
Food
Grade
10.4.1.1.3.
Others
10.4.1.2.
U.S
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Application
10.4.1.2.1.
Dietary
Supplement
10.4.1.2.2.
Pharmaceutical
Industry
10.4.1.2.3.
Others
10.4.2. Canada
10.4.2.1.
Canada
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Type
10.4.2.1.1.
Pharmaceutical
Grade
10.4.2.1.2.
Food
Grade
10.4.2.1.3.
Others
10.4.2.2.
Canada
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Application
10.4.2.2.1.
Dietary
Supplement
10.4.2.2.2.
Pharmaceutical
Industry
10.4.2.2.3.
Others
10.4.3. Mexico
10.4.3.1.
Mexico
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Type
10.4.3.1.1.
Pharmaceutical
Grade
10.4.3.1.2.
Food
Grade
10.4.3.1.3.
Others
10.4.3.2.
Mexico
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Application
10.4.3.2.1.
Dietary
Supplement
10.4.3.2.2.
Pharmaceutical
Industry
10.4.3.2.3.
Others
10.4.4. Rest of North America
10.4.4.1.
Rest of
North America Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn)
and Forecasts, By Type
10.4.4.1.1.
Pharmaceutical
Grade
10.4.4.1.2.
Food
Grade
10.4.4.1.3.
Others
10.4.4.2.
Rest of
North America Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn)
and Forecasts, By Application
10.4.4.2.1.
Dietary
Supplement
10.4.4.2.2.
Pharmaceutical
Industry
10.4.4.2.3.
Others
10.5. Key Segment for Channeling Investments
10.5.1. By Country
10.5.2. By Type
10.5.3. By Application
11. Europe Nicotinamide Adenine Dinucleotide
(NAD) Market Analysis and Forecasts, 2022 - 2030
11.1. Overview
11.1.1. Europe Nicotinamide Adenine Dinucleotide
(NAD) Market Revenue (US$ Mn)
11.2. Europe Nicotinamide Adenine Dinucleotide
(NAD) Market Revenue (US$ Mn) and Forecasts, By Type
11.2.1. Pharmaceutical Grade
11.2.2. Food Grade
11.2.3. Others
11.3. Europe Nicotinamide Adenine Dinucleotide
(NAD) Market Revenue (US$ Mn) and Forecasts, By Application
11.3.1. Dietary Supplement
11.3.2. Pharmaceutical Industry
11.3.3. Others
11.4. Europe Nicotinamide Adenine Dinucleotide
(NAD) Market Revenue (US$ Mn) and Forecasts, By Country
11.4.1. France
11.4.1.1.
France
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Type
11.4.1.1.1.
Pharmaceutical
Grade
11.4.1.1.2.
Food
Grade
11.4.1.1.3.
Others
11.4.1.2.
France
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Application
11.4.1.2.1.
Dietary
Supplement
11.4.1.2.2.
Pharmaceutical
Industry
11.4.1.2.3.
Others
11.4.2. The UK
11.4.2.1.
The UK
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Type
11.4.2.1.1.
Pharmaceutical
Grade
11.4.2.1.2.
Food
Grade
11.4.2.1.3.
Others
11.4.2.2.
The UK
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Application
11.4.2.2.1.
Dietary
Supplement
11.4.2.2.2.
Pharmaceutical
Industry
11.4.2.2.3.
Others
11.4.3. Spain
11.4.3.1.
Spain
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Type
11.4.3.1.1.
Pharmaceutical
Grade
11.4.3.1.2.
Food
Grade
11.4.3.1.3.
Others
11.4.3.2.
Spain
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Application
11.4.3.2.1.
Dietary
Supplement
11.4.3.2.2.
Pharmaceutical
Industry
11.4.3.2.3.
Others
11.4.4. Germany
11.4.4.1.
Germany
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Type
11.4.4.1.1.
Pharmaceutical
Grade
11.4.4.1.2.
Food
Grade
11.4.4.1.3.
Others
11.4.4.2.
Germany
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Application
11.4.4.2.1.
Dietary
Supplement
11.4.4.2.2.
Pharmaceutical
Industry
11.4.4.2.3.
Others
11.4.5. Italy
11.4.5.1.
Italy
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Type
11.4.5.1.1.
Pharmaceutical
Grade
11.4.5.1.2.
Food
Grade
11.4.5.1.3.
Others
11.4.5.2.
Italy
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Application
11.4.5.2.1.
Dietary
Supplement
11.4.5.2.2.
Pharmaceutical
Industry
11.4.5.2.3.
Others
11.4.6. Nordic Countries
11.4.6.1.
Nordic Countries
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Type
11.4.6.1.1.
Pharmaceutical
Grade
11.4.6.1.2.
Food
Grade
11.4.6.1.3.
Others
11.4.6.2.
Nordic
Countries Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and
Forecasts, By Application
11.4.6.2.1.
Dietary
Supplement
11.4.6.2.2.
Pharmaceutical
Industry
11.4.6.2.3.
Others
11.4.6.3.
Nordic
Countries Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and
Forecasts, By Country
11.4.6.3.1.
Denmark
11.4.6.3.2.
Finland
11.4.6.3.3.
Iceland
11.4.6.3.4.
Sweden
11.4.6.3.5.
Norway
11.4.7. Benelux Union
11.4.7.1.
Benelux
Union Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and
Forecasts, By Type
11.4.7.1.1.
Pharmaceutical
Grade
11.4.7.1.2.
Food
Grade
11.4.7.1.3.
Others
11.4.7.2.
Benelux
Union Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and
Forecasts, By Application
11.4.7.2.1.
Dietary
Supplement
11.4.7.2.2.
Pharmaceutical
Industry
11.4.7.2.3.
Others
11.4.7.3.
Benelux
Union Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and
Forecasts, By Country
11.4.7.3.1.
Belgium
11.4.7.3.2.
The
Netherlands
11.4.7.3.3.
Luxembourg
11.4.8. Rest of Europe
11.4.8.1.
Rest of
Europe Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and
Forecasts, By Type
11.4.8.1.1.
Pharmaceutical
Grade
11.4.8.1.2.
Food
Grade
11.4.8.1.3.
Others
11.4.8.2.
Rest of
Europe Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and
Forecasts, By Application
11.4.8.2.1.
Dietary
Supplement
11.4.8.2.2.
Pharmaceutical
Industry
11.4.8.2.3.
Others
11.5. Key Segment for Channeling Investments
11.5.1. By Country
11.5.2. By Type
11.5.3. By Application
12. Asia Pacific Nicotinamide Adenine
Dinucleotide (NAD) Market Analysis and Forecasts, 2022 - 2030
12.1. Overview
12.1.1. Asia Pacific Nicotinamide Adenine
Dinucleotide (NAD) Market Revenue (US$ Mn)
12.2. Asia Pacific Nicotinamide Adenine
Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts, By Type
12.2.1. Pharmaceutical Grade
12.2.2. Food Grade
12.2.3. Others
12.3. Asia Pacific Nicotinamide Adenine
Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts, By Application
12.3.1. Dietary Supplement
12.3.2. Pharmaceutical Industry
12.3.3. Others
12.4. Asia Pacific Nicotinamide Adenine
Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts, By Country
12.4.1. China
12.4.1.1.
China
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Type
12.4.1.1.1.
Pharmaceutical
Grade
12.4.1.1.2.
Food
Grade
12.4.1.1.3.
Others
12.4.1.2.
China
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Application
12.4.1.2.1.
Dietary
Supplement
12.4.1.2.2.
Pharmaceutical
Industry
12.4.1.2.3.
Others
12.4.2. Japan
12.4.2.1.
Japan
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Type
12.4.2.1.1.
Pharmaceutical
Grade
12.4.2.1.2.
Food
Grade
12.4.2.1.3.
Others
12.4.2.2.
Japan
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Application
12.4.2.2.1.
Dietary
Supplement
12.4.2.2.2.
Pharmaceutical
Industry
12.4.2.2.3.
Others
12.4.3. India
12.4.3.1.
India
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Type
12.4.3.1.1.
Pharmaceutical
Grade
12.4.3.1.2.
Food
Grade
12.4.3.1.3.
Others
12.4.3.2.
India
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Application
12.4.3.2.1.
Dietary
Supplement
12.4.3.2.2.
Pharmaceutical
Industry
12.4.3.2.3.
Others
12.4.4. New Zealand
12.4.4.1.
New
Zealand Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and
Forecasts, By Type
12.4.4.1.1.
Pharmaceutical
Grade
12.4.4.1.2.
Food
Grade
12.4.4.1.3.
Others
12.4.4.2.
New
Zealand Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and
Forecasts, By Application
12.4.4.2.1.
Dietary
Supplement
12.4.4.2.2.
Pharmaceutical
Industry
12.4.4.2.3.
Others
12.4.5. Australia
12.4.5.1.
Australia
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Type
12.4.5.1.1.
Pharmaceutical
Grade
12.4.5.1.2.
Food
Grade
12.4.5.1.3.
Others
12.4.5.2.
Australia
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Application
12.4.5.2.1.
Dietary
Supplement
12.4.5.2.2.
Pharmaceutical
Industry
12.4.5.2.3.
Others
12.4.6. South Korea
12.4.6.1.
South
Korea Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and
Forecasts, By Type
12.4.6.1.1.
Pharmaceutical
Grade
12.4.6.1.2.
Food
Grade
12.4.6.1.3.
Others
12.4.6.2.
South
Korea Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Application
12.4.6.2.1.
Dietary
Supplement
12.4.6.2.2.
Pharmaceutical
Industry
12.4.6.2.3.
Others
12.4.7. Southeast Asia
12.4.7.1.
Southeast
Asia Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and
Forecasts, By Type
12.4.7.1.1.
Pharmaceutical
Grade
12.4.7.1.2.
Food
Grade
12.4.7.1.3.
Others
12.4.7.2.
Southeast
Asia Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and
Forecasts, By Application
12.4.7.2.1.
Dietary
Supplement
12.4.7.2.2.
Pharmaceutical
Industry
12.4.7.2.3.
Others
12.4.7.3.
Southeast
Asia Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and
Forecasts, By Country
12.4.7.3.1.
Indonesia
12.4.7.3.2.
Thailand
12.4.7.3.3.
Malaysia
12.4.7.3.4.
Singapore
12.4.7.3.5.
Rest of
Southeast Asia
12.4.8. Rest of Asia Pacific
12.4.8.1.
Rest of
Asia Pacific Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn)
and Forecasts, By Type
12.4.8.1.1.
Pharmaceutical
Grade
12.4.8.1.2.
Food
Grade
12.4.8.1.3.
Others
12.4.8.2.
Rest of
Asia Pacific Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn)
and Forecasts, By Application
12.4.8.2.1.
Dietary
Supplement
12.4.8.2.2.
Pharmaceutical
Industry
12.4.8.2.3.
Others
12.5. Key Segment for Channeling Investments
12.5.1. By Country
12.5.2. By Type
12.5.3. By Application
13. Middle East and Africa Nicotinamide Adenine
Dinucleotide (NAD) Market Analysis and Forecasts, 2022 - 2030
13.1. Overview
13.1.1. Middle East and Africa Nicotinamide Adenine
Dinucleotide (NAD) Market Revenue (US$ Mn)
13.2. Middle East and Africa Nicotinamide Adenine
Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts, By Type
13.2.1. Pharmaceutical Grade
13.2.2. Food Grade
13.2.3. Others
13.3. Middle East and Africa Nicotinamide Adenine
Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts, By Application
13.3.1. Dietary Supplement
13.3.2. Pharmaceutical Industry
13.3.3. Others
13.4. Middle East and Africa Nicotinamide Adenine Dinucleotide
(NAD) Market Revenue (US$ Mn) and Forecasts, By Country
13.4.1. Saudi Arabia
13.4.1.1.
Saudi
Arabia Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and
Forecasts, By Type
13.4.1.1.1.
Pharmaceutical
Grade
13.4.1.1.2.
Food
Grade
13.4.1.1.3.
Others
13.4.1.2.
Saudi
Arabia Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and
Forecasts, By Application
13.4.1.2.1.
Dietary
Supplement
13.4.1.2.2.
Pharmaceutical
Industry
13.4.1.2.3.
Others
13.4.2. UAE
13.4.2.1.
UAE
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Type
13.4.2.1.1.
Pharmaceutical
Grade
13.4.2.1.2.
Food
Grade
13.4.2.1.3.
Others
13.4.2.2.
UAE
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Application
13.4.2.2.1.
Dietary
Supplement
13.4.2.2.2.
Pharmaceutical
Industry
13.4.2.2.3.
Others
13.4.3. Egypt
13.4.3.1.
Egypt
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Type
13.4.3.1.1.
Pharmaceutical
Grade
13.4.3.1.2.
Food
Grade
13.4.3.1.3.
Others
13.4.3.2.
Egypt
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Application
13.4.3.2.1.
Dietary
Supplement
13.4.3.2.2.
Pharmaceutical
Industry
13.4.3.2.3.
Others
13.4.4. Kuwait
13.4.4.1.
Kuwait
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Type
13.4.4.1.1.
Pharmaceutical
Grade
13.4.4.1.2.
Food
Grade
13.4.4.1.3.
Others
13.4.4.2.
Kuwait
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Application
13.4.4.2.1.
Dietary
Supplement
13.4.4.2.2.
Pharmaceutical
Industry
13.4.4.2.3.
Others
13.4.5. South Africa
13.4.5.1.
South
Africa Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and
Forecasts, By Type
13.4.5.1.1.
Pharmaceutical
Grade
13.4.5.1.2.
Food
Grade
13.4.5.1.3.
Others
13.4.5.2.
South
Africa Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and
Forecasts, By Application
13.4.5.2.1.
Dietary
Supplement
13.4.5.2.2.
Pharmaceutical
Industry
13.4.5.2.3.
Others
13.4.6. Rest of Middle East & Africa
13.4.6.1.
Rest of
Middle East & Africa Nicotinamide Adenine Dinucleotide (NAD) Market Revenue
(US$ Mn) and Forecasts, By Type
13.4.6.1.1.
Pharmaceutical
Grade
13.4.6.1.2.
Food
Grade
13.4.6.1.3.
Others
13.4.6.2.
Rest of
Middle East & Africa Nicotinamide Adenine Dinucleotide (NAD) Market Revenue
(US$ Mn) and Forecasts, By Application
13.4.6.2.1.
Dietary
Supplement
13.4.6.2.2.
Pharmaceutical
Industry
13.4.6.2.3.
Others
13.5. Key Segment for Channeling Investments
13.5.1. By Country
13.5.2. By Type
13.5.3. By Application
14. Latin America Nicotinamide Adenine
Dinucleotide (NAD) Market Analysis and Forecasts, 2022 - 2030
14.1. Overview
14.1.1. Latin America Nicotinamide Adenine
Dinucleotide (NAD) Market Revenue (US$ Mn)
14.2. Latin America Nicotinamide Adenine
Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts, By Type
14.2.1. Pharmaceutical Grade
14.2.2. Food Grade
14.2.3. Others
14.3. Latin America Nicotinamide Adenine
Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts, By Application
14.3.1. Dietary Supplement
14.3.2. Pharmaceutical Industry
14.3.3. Others
14.4. Latin America Nicotinamide Adenine
Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts, By Country
14.4.1. Brazil
14.4.1.1.
Brazil
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Type
14.4.1.1.1.
Pharmaceutical
Grade
14.4.1.1.2.
Food
Grade
14.4.1.1.3.
Others
14.4.1.2.
Brazil
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Application
14.4.1.2.1.
Dietary
Supplement
14.4.1.2.2.
Pharmaceutical
Industry
14.4.1.2.3.
Others
14.4.2. Argentina
14.4.2.1.
Argentina
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Type
14.4.2.1.1.
Pharmaceutical
Grade
14.4.2.1.2.
Food
Grade
14.4.2.1.3.
Others
14.4.2.2.
Argentina
Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn) and Forecasts,
By Application
14.4.2.2.1.
Dietary
Supplement
14.4.2.2.2.
Pharmaceutical
Industry
14.4.2.2.3.
Others
14.4.3. Rest of Latin America
14.4.3.1.
Rest of
Latin America Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn)
and Forecasts, By Type
14.4.3.1.1.
Pharmaceutical
Grade
14.4.3.1.2.
Food
Grade
14.4.3.1.3.
Others
14.4.3.2.
Rest of
Latin America Nicotinamide Adenine Dinucleotide (NAD) Market Revenue (US$ Mn)
and Forecasts, By Application
14.4.3.2.1.
Dietary
Supplement
14.4.3.2.2.
Pharmaceutical
Industry
14.4.3.2.3.
Others
14.5. Key Segment for Channeling Investments
14.5.1. By Country
14.5.2. By Type
14.5.3. By Application
15. Competitive Benchmarking
15.1. Brand Benchmarking
15.2. Market Share Analysis, 2021
15.3. Global Presence and Growth Strategies
15.3.1. Mergers and Acquisitions
15.3.2. Product Launches
15.3.3. Investments Trends
15.3.4. R&D Initiatives
16. Player Profiles
16.1. Bontac Bio-engineering(shenzhen)co.,ltd
16.1.1. Company Details
16.1.2. Company Overview
16.1.3. Product Offerings
16.1.4. Key Developments
16.1.5. Financial Analysis
16.1.6. SWOT Analysis
16.1.7. Business Strategies
16.2. Catalent, Inc
16.2.1. Company Details
16.2.2. Company Overview
16.2.3. Product Offerings
16.2.4. Key Developments
16.2.5. Financial Analysis
16.2.6. SWOT Analysis
16.2.7. Business Strategies
16.3. Jubilant Life Sciences
16.3.1. Company Details
16.3.2. Company Overview
16.3.3. Product Offerings
16.3.4. Key Developments
16.3.5. Financial Analysis
16.3.6. SWOT Analysis
16.3.7. Business Strategies
16.4. Koninklijke DSM N.V.
16.4.1. Company Details
16.4.2. Company Overview
16.4.3. Product Offerings
16.4.4. Key Developments
16.4.5. Financial Analysis
16.4.6. SWOT Analysis
16.4.7. Business Strategies
16.5. Lasons India Pvt. Ltd
16.5.1. Company Details
16.5.2. Company Overview
16.5.3. Product Offerings
16.5.4. Key Developments
16.5.5. Financial Analysis
16.5.6. SWOT Analysis
16.5.7. Business Strategies
16.6. Lonza Group Ltd
16.6.1. Company Details
16.6.2. Company Overview
16.6.3. Product Offerings
16.6.4. Key Developments
16.6.5. Financial Analysis
16.6.6. SWOT Analysis
16.6.7. Business Strategies
16.7. Novo Nordisk A/S
16.7.1. Company Details
16.7.2. Company Overview
16.7.3. Product Offerings
16.7.4. Key Developments
16.7.5. Financial Analysis
16.7.6. SWOT Analysis
16.7.7. Business Strategies
16.8. Resonance Specialties Limited
16.8.1. Company Details
16.8.2. Company Overview
16.8.3. Product Offerings
16.8.4. Key Developments
16.8.5. Financial Analysis
16.8.6. SWOT Analysis
16.8.7. Business Strategies
16.9. TCI Chemicals (India) Pvt. Ltd.
16.9.1. Company Details
16.9.2. Company Overview
16.9.3. Product Offerings
16.9.4. Key Developments
16.9.5. Financial Analysis
16.9.6. SWOT Analysis
16.9.7. Business Strategies
16.10. Vertellus Holdings LLC
16.10.1. Company Details
16.10.2. Company Overview
16.10.3. Product Offerings
16.10.4. Key Developments
16.10.5. Financial Analysis
16.10.6. SWOT Analysis
16.10.7. Business Strategies
16.11. Zhejiang Lanbo Biotechnology Co., Ltd.
16.11.1. Company Details
16.11.2. Company Overview
16.11.3. Product Offerings
16.11.4. Key Developments
16.11.5. Financial Analysis
16.11.6. SWOT Analysis
16.11.7. Business Strategies
16.12. Other Market Participants
17. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User
and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.